Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis

被引:33
|
作者
Palmieri, Vincenzo O. [1 ]
Santovito, Daniela [1 ]
Margari, Francesco [2 ]
Lozupone, Madia [2 ]
Minerva, Francesco [1 ]
Di Gennaro, Carla [1 ]
Todarello, Orlando [2 ]
Palasciano, Giuseppe [1 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Clin Med A Murri, I-70124 Bari, Italy
[2] Univ Bari, Dept Basic Med Sci Neurosci & Sensorial Organs, I-70124 Bari, Italy
关键词
Hepatocellular carcinoma; Liver cirrhosis; Health-related quality of life; Psychopathological profile; RANDOMIZED CONTROLLED-TRIAL; CANCER SURVIVORS; RATING-SCALE; ALEXITHYMIA; DEPRESSION; CHINESE; SATISFACTION; RELIABILITY; VALIDATION; SYMPTOMS;
D O I
10.1007/s10238-013-0267-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In some tumors, psychosocial interventions may enhance health-related quality of life (HRQOL) of patients. The effects of psychological variables on HRQOL in hepatocellular carcinoma (HCC) patients have been rarely assessed. The aim of this work is to evaluate the psychopathological profile of HCC and cirrhotic patients and its effect on HRQOL. Twenty-four HCC patients (median age 71, Child A 21, Child B 3), 22 cirrhotic patients (median age 68, Child A 20, Child B 2) and 20 control subjects were included in this study. Each subject completes four questionnaires: medical outcomes study short form-36 (SF-36, HRQOL evaluation); Hamilton-D (quantitative evaluation of depression; positive a parts per thousand yen8); symptom check list 90-revised (SCL 90-R, general psychopathological profile; nine domains, each positive > 1); Toronto alexithymia scale (TAS 20) (positive a parts per thousand yen60). SCL 90-R: cirrhotic patients differ from HCC subjects for somatization (SOM) (M +/- A SD 1.09 +/- A 0.6 vs 0.65 +/- A 0.6; p = 0.01) and anxiety (M +/- A SD 0.85 +/- A 0.46 vs 0.58 +/- A 0.38; p = 0.01) items. TAS 20: positive in 50 % of HCC patients, in 54 % of cirrhotic patients (p = n.s.) and in none of controls. Hamilton-D: higher scores in cirrhotic patients than in the HCC group (86 vs 46 %; p = 0.005). SF-36: each item, except bodily pain, is lower in both group of patients in comparison with controls. Pearson correlation analysis shows negative correlations on HRQOL of depression, SOM and anxiety both in cirrhotic and HCC subjects, also of obsessive-compulsive and hostility items in HCC. This is the first report on the psychopathological profile of HCC patients: the results open questions on the role of psychological interventions that may improve HRQOL of patients before treatment and in the follow-up.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [1] Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis
    Vincenzo O. Palmieri
    Daniela Santovito
    Francesco Margari
    Madia Lozupone
    Francesco Minerva
    Carla Di Gennaro
    Orlando Todarello
    Giuseppe Palasciano
    Clinical and Experimental Medicine, 2015, 15 : 65 - 72
  • [2] PSYCOLOGICAL PROFILE AND HEALTH RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
    Palmieri, V. O.
    Lozupone, M.
    de Bonfils, P.
    Barberio, M.
    Minerva, F.
    Todarello, O.
    Palasciano, G.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S291 - S291
  • [3] Health-related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)
    Vogel, Arndt
    Qin, Shukui
    Kudo, Masatoshi
    Hudgens, Stacie
    Yamashita, Tatsuya
    Yoon, Jung-Hwan
    Fartoux, Laetitia
    Simon, Krzysztof
    Lopez, Carlos L.
    Sung, Max
    Dutcus, Corina E.
    Kraljevic, Silvija
    Tamai, Toshiyuki
    Grunow, Nathan
    Meier, Genevieve
    Breder, Valeriy
    HEPATOLOGY, 2017, 66 : 734A - 734A
  • [4] HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND DISEASE SYMPTOMS IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB (LEN) OR SORAFENIB (SOR)
    Vogel, A.
    Qin, S.
    Kudo, M.
    Hudgens, S.
    Yamashita, T.
    Yoon, J.
    Fartoux, L.
    Simon, K.
    Lopez, C.
    Sung, M.
    Dutcus, C.
    Kraljevic, S.
    Tamai, T.
    Grunow, N.
    Meier, G.
    Breder, V
    VALUE IN HEALTH, 2017, 20 (09) : A454 - A455
  • [5] Health-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR)
    Vogel, A.
    Qin, S.
    Kudo, M.
    Hudgens, S.
    Yamashita, T.
    Yoon, J-H.
    Fartoux, L.
    Simon, K.
    Lopez Lopez, C.
    Sung, M.
    Dutcus, C.
    Kraljevic, S.
    Tamai, T.
    Grunow, N.
    Meier, G.
    Breder, V.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Factors Associated with Health-Related Quality of Life (HRQoL) in Patients with Decompensated Cirrhosis
    Rabiee, Anahita
    Ximenes, Rafael Oliveira
    Nikayin, Sina
    Hickner, Andrew Lawrence
    Garcia-Tsao, Guadalupe
    HEPATOLOGY, 2018, 68 : 464A - 465A
  • [7] Systematic Review of Instruments Evaluating Health-Related Quality of Life (HRQoL) in Patients with Cirrhosis
    Rabiee, Anahita
    Nikayin, Sina
    Ximenes, Rafael Oliveira
    Juthani, Prerak Vipul
    Hickner, Andrew Lawrence
    Garcia-Tsao, Guadalupe
    HEPATOLOGY, 2018, 68 : 457A - 458A
  • [8] Health-related quality of life in patients with cirrhosis
    Amarasena, S.
    Bernardes, C.
    Stuart, K.
    Gupta, R.
    Horsfall, L.
    Rahman, T.
    Clark, P.
    Skoien, R.
    Hartel, G.
    Hayward, K.
    Powell, E.
    Valery, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 77 - 77
  • [9] Health-related quality of life in unresectable hepatocellular carcinoma (HCC) in patients treated with TACE or 90-Yttrium.
    Steel, JL
    Olek, M
    Carr, BI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 766S - 766S
  • [10] Health-related quality of life (HRQOL) in Polish epilepsy patients
    Nicpon, KW
    Szaflarski, JP
    Wrobel, E
    Szaflarskil, M
    EPILEPSIA, 2004, 45 : 86 - 86